This finding provides the first direct evidence that GIP strongly increases LOX expression, and supports the hypothesis that loss of GIP regulation of LOX in diabetes could contribute to decreased collagen crosslinking and osteopenia observed in diabetes. The gene discussed is LOX; the disease is Osteopenia.